Similarly, EGFR inhibitor-stimulated production and secretion of TGFβ2 functions as an autocrine growth factor in HNSCC cells [37], but is predicted to exert diverse effects on the TME, including the immune microenvironment. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.